Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: Elevated galectin-3 levels detected in women with hyperglycemia during early and mid-pregnancy antagonizes high glucose − induced trophoblast cells apoptosis via galectin-3/foxc1 pathway

Fig. 1

The plasma galectin-3 levels during pregnancy. (A) Flowchart of the study for detecting plasma galectin-3 levels by using enzyme-linked immunosorbent assay (ELISA). (B) Plasma galectin-3 levels in gestational diabetes mellitus (GDM) and healthy pregnant women (HP) groups during pregnancy. (C-D) Plasma galectin-3 levels between GDM with the normal weight group (pre-pregnancy BMI ≥ 18.5 and < 24.0 kg/m2) and HP with the normal weight group (pre-pregnancy BMI ≥ 18.5 and < 24.0 kg/m2) during the first (C) and second (D) trimesters. Correlation between plasma galectin-3 levels and pre-pregnancy BMI (left panel). GDM with the normal weight group had significant higher maternal plasma galectin-3 levels than HP with the normal weight group (middle panel). The GDM with the normal weight group and HP with the normal weight group had similar pre-pregnancy BMI (right panel). n.s., no significant difference. *: P < 0.05, **: P < 0.01

Back to article page

Molecular Medicine

ISSN: 1528-3658